We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-2.35%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.85B
AUM Growth
+$132M
Cap. Flow
+$223M
Cap. Flow %
7.84%
Top 10 Hldgs %
64.12%
Holding
111
New
25
Increased
23
Reduced
13
Closed
26

Top Buys

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$172M
2
MET icon
MetLife
MET
+$21.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$13.5M
4
AIG icon
American International
AIG
+$13.4M
5
DG icon
Dollar General
DG
+$13M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$32.6M
2
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$28.1M
3
IMGN
Immunogen Inc
IMGN
+$13.7M
4
BABA icon
Alibaba
BABA
+$12.8M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$8.93M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.65%
2 Healthcare 21.49%
3 Financials 2.87%
4 Communication Services 1.25%
5 Industrials 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONIT
101
CALL
Onity Group
ONIT
$346M
– –
-10,000
Closed -$3.93M
IMGN
102
DELISTED
Immunogen Inc
IMGN
– –
-1,500,000
Closed -$13.7M
CSLT
103
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-100,000
Closed -$1.29M
STML
104
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-170,000
Closed -$2.12M
TFCFA
105
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
– –
-200,000
Closed -$6.86M
MON
106
CALL
DELISTED
Monsanto Co
MON
– –
-50,000
Closed -$5.63M
SFXE
107
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
– –
-250,000
Closed -$1.25M
FSL
108
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
– –
-350,000
Closed -$6.84M
AUXL
109
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-1,000,000
Closed -$32.6M
AVNR
110
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
– –
-2,000,000
Closed -$28.1M
SPHS
111
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-1,000,000
Closed -$2.93M
1 2 3 4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2014 Portfolio in Review

As of Q4 2014, Artal Group held 111 positions worth $2.85B, up 4.9% from $2.72B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Artal Group deployed $223M of net new capital in Q4 2014, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was MetLife: 448,800 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $12.8M trimmed.

  • Artal Group's largest Q4 2014 buy was MetLife: 448,800 shares worth $21.6M.
  • Artal Group added most to Lexicon Pharmaceuticals in Q4 2014, an estimated $172M increase.
  • Artal Group's biggest Q4 2014 reduction was Alibaba, cutting an estimated $12.8M.
  • Artal Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $32.6M.
  • Artal Group's ten largest holdings make up 64% of its $2.85B portfolio in Q4 2014.
  • Artal Group opened 25 new positions and closed 26 in Q4 2014.
  • Artal Group's portfolio value rose 4.9% quarter-over-quarter to $2.85B.

Based on Artal Group's 13F filing for Q4 2014, filed 13 Feb 2015.